Disease: Muscle Weakness ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0151786
Disease: Muscle Weakness
Muscle Weakness 		0.120 Biomarker phenotype BEFREE Anti-MDA5 was originally characterized in Japan in DM patients with hallmark cutaneous features and no proximal muscle weakness and termed clinically amyopathic DM (CADM). 30382445 2018
CUI: C0151786
Disease: Muscle Weakness
Muscle Weakness 		0.120 AlteredExpression phenotype BEFREE Anti-MDA5 were originally identified in a clinically-defined subset of DM patients whose disease was expressed predominately in the skin for unusually long periods of time without accompanying muscle weakness [i.e., "clinically-amyopathic DM" (CADM)] and were at risk for acute, rapidly-progressive form of interstitial lung disease (ILD). 28480196 2017
CUI: C0151786
Disease: Muscle Weakness
Muscle Weakness 		0.120 Biomarker phenotype HPO